MLTX — MOONLAKE IMMUNOTHERAPEUTICS

Ownership history in BVF INC/IL  ·  15 quarters on record

This page tracks every 13F SEC filing in which BVF INC/IL reported a position in MOONLAKE IMMUNOTHERAPEUTICS (MLTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
36.25% (2024 Q4)
Avg. % of fund
22.73%
First filed
2022 Q2
Last filed
2025 Q4
Quarters held
15
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 19,751,284 — 0% 8.76% $260.3M $13.18
2025 Q3 UNCHANGED 19,751,284 — 0% 5.74% $141.6M $7.17
2025 Q2 UNCHANGED 19,751,284 — 0% 33.31% $932.3M $47.20
2025 Q1 UNCHANGED 19,751,284 — 0% 31.45% $771.7M $39.07
11 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    MLTX price (monthly, adj. close)

Other funds also holding MLTX

As of 2025 Q4 — sorted by position size

Lion Point Capital, LP 3Y 7Y 4.6% Cormorant Asset Management, LP 3Y 7Y 2.65% Logos Global Management LP 3Y 1.39% Deep Track Capital, LP 3Y 1.08% Vivo Capital, LLC 3Y 7Y 0.85% STEMPOINT CAPITAL LP 0.79% Eagle Health Investments LP 3Y 0.54% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 0.53% Rhenman & Partners Asset Management AB 3Y 7Y 0.45% First Turn Management, LLC 0.4%
← Back to BVF INC/IL Holdings